Global Biosimilar Market Professional Survey Report 2017

August 2017 | 100 pages | ID: G0C11C87F94EN
QYResearch

Abstracts

This report studies Biosimilar in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Roche
• Eli Lilly
• Bayer
• Amgen
• Sanofi-Aventis
• Johnson & Johnson
• Novo Nordisk
• Merck

By types, the market can be split into

• Antibody
• Hormone
• Growth Factors
• Other

By Application, the market can be split into

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Biosimilar Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF BIOSIMILAR

1.1 Definition and Specifications of Biosimilar
  1.1.1 Definition of Biosimilar
  1.1.2 Specifications of Biosimilar
1.2 Classification of Biosimilar
  1.2.1 Antibody
  1.2.2 Hormone
  1.2.3 Growth Factors
  1.2.4 Other
1.3 Applications of Biosimilar
  1.3.1 Tumor
  1.3.2 Diabetes
  1.3.3 Cardiovascular
  1.3.4 Hemophilia
  1.3.5 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOSIMILAR

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilar
2.3 Manufacturing Process Analysis of Biosimilar
2.4 Industry Chain Structure of Biosimilar

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIOSIMILAR

3.1 Capacity and Commercial Production Date of Global Biosimilar Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Biosimilar Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Biosimilar Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Biosimilar Major Manufacturers in 2016

4 GLOBAL BIOSIMILAR OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Biosimilar Capacity and Growth Rate Analysis
  4.2.2 2016 Biosimilar Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Biosimilar Sales and Growth Rate Analysis
  4.3.2 2016 Biosimilar Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Biosimilar Sales Price
  4.4.2 2016 Biosimilar Sales Price Analysis (Company Segment)

5 BIOSIMILAR REGIONAL MARKET ANALYSIS

5.1 North America Biosimilar Market Analysis
  5.1.1 North America Biosimilar Market Overview
  5.1.2 North America 2012-2017E Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Biosimilar Sales Price Analysis
  5.1.4 North America 2016 Biosimilar Market Share Analysis
5.2 China Biosimilar Market Analysis
  5.2.1 China Biosimilar Market Overview
  5.2.2 China 2012-2017E Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Biosimilar Sales Price Analysis
  5.2.4 China 2016 Biosimilar Market Share Analysis
5.3 Europe Biosimilar Market Analysis
  5.3.1 Europe Biosimilar Market Overview
  5.3.2 Europe 2012-2017E Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Biosimilar Sales Price Analysis
  5.3.4 Europe 2016 Biosimilar Market Share Analysis
5.4 Southeast Asia Biosimilar Market Analysis
  5.4.1 Southeast Asia Biosimilar Market Overview
  5.4.2 Southeast Asia 2012-2017E Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Biosimilar Sales Price Analysis
  5.4.4 Southeast Asia 2016 Biosimilar Market Share Analysis
5.5 Japan Biosimilar Market Analysis
  5.5.1 Japan Biosimilar Market Overview
  5.5.2 Japan 2012-2017E Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Biosimilar Sales Price Analysis
  5.5.4 Japan 2016 Biosimilar Market Share Analysis
5.6 India Biosimilar Market Analysis
  5.6.1 India Biosimilar Market Overview
  5.6.2 India 2012-2017E Biosimilar Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Biosimilar Sales Price Analysis
  5.6.4 India 2016 Biosimilar Market Share Analysis

6 GLOBAL 2012-2017E BIOSIMILAR SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Biosimilar Sales by Type
6.2 Different Types of Biosimilar Product Interview Price Analysis
6.3 Different Types of Biosimilar Product Driving Factors Analysis
  6.3.1 Antibody of Biosimilar Growth Driving Factor Analysis
  6.3.2 Hormone of Biosimilar Growth Driving Factor Analysis
  6.3.3 Growth Factors of Biosimilar Growth Driving Factor Analysis
  6.3.4 Other of Biosimilar Growth Driving Factor Analysis

7 GLOBAL 2012-2017E BIOSIMILAR SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Biosimilar Consumption by Application
7.2 Different Application of Biosimilar Product Interview Price Analysis
7.3 Different Application of Biosimilar Product Driving Factors Analysis
  7.3.1 Tumor of Biosimilar Growth Driving Factor Analysis
  7.3.2 Diabetes of Biosimilar Growth Driving Factor Analysis
  7.3.3 Cardiovascular of Biosimilar Growth Driving Factor Analysis
  7.3.4 Hemophilia of Biosimilar Growth Driving Factor Analysis
  7.3.5 Other of Biosimilar Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF BIOSIMILAR

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pfizer 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2016 Biosimilar Business Region Distribution Analysis
8.2 Roche
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Roche 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Roche 2016 Biosimilar Business Region Distribution Analysis
8.3 Eli Lilly
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Eli Lilly 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Eli Lilly 2016 Biosimilar Business Region Distribution Analysis
8.4 Bayer
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Bayer 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Bayer 2016 Biosimilar Business Region Distribution Analysis
8.5 Amgen
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Amgen 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Amgen 2016 Biosimilar Business Region Distribution Analysis
8.6 Sanofi-Aventis
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Sanofi-Aventis 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Sanofi-Aventis 2016 Biosimilar Business Region Distribution Analysis
8.7 Johnson & Johnson
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Johnson & Johnson 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Johnson & Johnson 2016 Biosimilar Business Region Distribution Analysis
8.8 Novo Nordisk
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Novo Nordisk 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Novo Nordisk 2016 Biosimilar Business Region Distribution Analysis
8.9 Merck
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Merck 2016 Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Merck 2016 Biosimilar Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF BIOSIMILAR MARKET

9.1 Global Biosimilar Market Trend Analysis
  9.1.1 Global 2017-2022 Biosimilar Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Biosimilar Sales Price Forecast
9.2 Biosimilar Regional Market Trend
  9.2.1 North America 2017-2022 Biosimilar Consumption Forecast
  9.2.2 China 2017-2022 Biosimilar Consumption Forecast
  9.2.3 Europe 2017-2022 Biosimilar Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Biosimilar Consumption Forecast
  9.2.5 Japan 2017-2022 Biosimilar Consumption Forecast
  9.2.6 India 2017-2022 Biosimilar Consumption Forecast
9.3 Biosimilar Market Trend (Product Type)
9.4 Biosimilar Market Trend (Application)

10 BIOSIMILAR MARKETING TYPE ANALYSIS

10.1 Biosimilar Regional Marketing Type Analysis
10.2 Biosimilar International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Biosimilar by Region
10.4 Biosimilar Supply Chain Analysis

11 CONSUMERS ANALYSIS OF BIOSIMILAR

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL BIOSIMILAR MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar
Table Product Specifications of Biosimilar
Table Classification of Biosimilar
Figure Global Production Market Share of Biosimilar by Type in 2016
Figure Antibody Picture
Table Major Manufacturers of Antibody
Figure Hormone Picture
Table Major Manufacturers of Hormone
Figure Growth Factors Picture
Table Major Manufacturers of Growth Factors
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Biosimilar
Figure Global Consumption Volume Market Share of Biosimilar by Application in 2016
Figure Tumor Examples
Table Major Consumers in Tumor
Figure Diabetes Examples
Table Major Consumers in Diabetes
Figure Cardiovascular Examples
Table Major Consumers in Cardiovascular
Figure Hemophilia Examples
Table Major Consumers in Hemophilia
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Biosimilar by Regions
Figure North America Biosimilar Market Size (Million USD) (2012-2022)
Figure China Biosimilar Market Size (Million USD) (2012-2022)
Figure Europe Biosimilar Market Size (Million USD) (2012-2022)
Figure Southeast Asia Biosimilar Market Size (Million USD) (2012-2022)
Figure Japan Biosimilar Market Size (Million USD) (2012-2022)
Figure India Biosimilar Market Size (Million USD) (2012-2022)
Table Biosimilar Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilar in 2016
Figure Manufacturing Process Analysis of Biosimilar
Figure Industry Chain Structure of Biosimilar
Table Capacity and Commercial Production Date of Global Biosimilar Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Biosimilar Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Biosimilar Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Biosimilar Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Biosimilar 2012-2017
Figure Global 2012-2017E Biosimilar Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Biosimilar Market Size (Value) and Growth Rate
Table 2012-2017E Global Biosimilar Capacity and Growth Rate
Table 2016 Global Biosimilar Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Biosimilar Sales (K Units) and Growth Rate
Table 2016 Global Biosimilar Sales (K Units) List (Company Segment)
Table 2012-2017E Global Biosimilar Sales Price (USD/Unit)
Table 2016 Global Biosimilar Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Biosimilar 2012-2017E
Figure North America 2012-2017E Biosimilar Sales Price (USD/Unit)
Figure North America 2016 Biosimilar Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Biosimilar 2012-2017E
Figure China 2012-2017E Biosimilar Sales Price (USD/Unit)
Figure China 2016 Biosimilar Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Biosimilar 2012-2017E
Figure Europe 2012-2017E Biosimilar Sales Price (USD/Unit)
Figure Europe 2016 Biosimilar Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Biosimilar 2012-2017E
Figure Southeast Asia 2012-2017E Biosimilar Sales Price (USD/Unit)
Figure Southeast Asia 2016 Biosimilar Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Biosimilar 2012-2017E
Figure Japan 2012-2017E Biosimilar Sales Price (USD/Unit)
Figure Japan 2016 Biosimilar Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Biosimilar 2012-2017E
Figure India 2012-2017E Biosimilar Sales Price (USD/Unit)
Figure India 2016 Biosimilar Sales Market Share
Table Global 2012-2017E Biosimilar Sales (K Units) by Type
Table Different Types Biosimilar Product Interview Price
Table Global 2012-2017E Biosimilar Sales (K Units) by Application
Table Different Application Biosimilar Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Biosimilar Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Biosimilar Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2015 Eli Lilly Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lilly Biosimilar Business Region Distribution
Table Bayer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bayer Biosimilar Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Biosimilar Business Region Distribution
Table Sanofi-Aventis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi-Aventis Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi-Aventis Biosimilar Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Biosimilar Business Region Distribution
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novo Nordisk Biosimilar Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck Biosimilar Business Region Distribution
Figure Global 2017-2022 Biosimilar Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Biosimilar Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Biosimilar Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Biosimilar by Type 2017-2022
Table Global Consumption Volume (K Units) of Biosimilar by Application 2017-2022
Table Traders or Distributors with Contact Information of Biosimilar by Region